Founding Partner ProgramShape grounded healthcare AI with us.Launch pricing, priority implementation and direct access to our team. Limited spots.Apply now

Home / What We Solve

What we solve

Data your leaders and AI can trust and use.

Most organizations don't lack data. They lack data their leaders and AI systems can trust and use. Here are the problems we hear first, why they happen, and what changes when one governed data foundation answers them.

The executive problem

Four problems we hear first.

  1. 01

    Fragmented

    Critical information is scattered across applications, platforms and silos.

    Answered byData Modernization

  2. 02

    Untrusted

    Conflicting definitions, uneven quality and unclear ownership erode confidence.

    Answered byAI Readiness

  3. 03

    Expensive

    Legacy architecture, duplication and point solutions slow every delivery.

    Answered byData Modernization

  4. 04

    Underused

    Analytics and AI stall on a foundation that is incomplete, inaccessible or ungoverned.

    Answered byAI Enablement

Root causesTechnical and organizational

The causes are rarely only technical.

In the architecture

  • Fragmented platforms and point-to-point pipelines
  • No agreed definitions: every report defines its own metrics
  • Legacy estate kept alive beside the new platform
  • No path from pilot to governed production

In the operating model

  • No named owner for the data that matters most
  • No decision rights when definitions conflict
  • AI pilots without a business owner
  • Modernization measured by migration, not by outcome

See which service answers each cause

Before you call usThree tests, almost no cost

Three tests you can run on Monday.

  1. Reconcile three metrics.Ask four departments for length of stay, readmission rate and ED boarding hours for the same month. The spread is your business case.
  2. Measure identity and terminology.Patient duplicate rate, cross-setting match rate, LOINC and SNOMED coverage. They decide how long a Patient 360 will take.
  3. Name the owners.Six to ten people who each own specific data and know it. If the list can’t be assembled, no platform decision will matter.

The full version: the Data & AI Readiness Assessment

What goes wrong

Five ways data and AI programs fail. We've seen each one.

  1. 01

    AI pilots that never reach production

    Why it happensBuilt on a curated extract, with no governed data or named owner.

    What we do insteadDesign the first use case for production; reuse the foundation for the next.

  2. 02

    Platforms that don't create value

    Why it happensThe migration became the goal; the decisions it served were never named.

    What we do insteadSequence by the decisions it unlocks; measure time to value, not tables moved.

  3. 03

    Governance that becomes bureaucracy

    Why it happensPolicies written for committees, not built into the platform.

    What we do insteadControls in the platform, so governed data is also the fastest to use.

  4. 04

    Five definitions of the same number

    Why it happensMeaning lives in reports, so every team encodes its own.

    What we do insteadOne agreed, documented definition, owned and versioned, for BI and AI alike.

  5. 05

    Modernization programs that overrun

    Why it happensEverything moves at once; value waits for the last workload.

    What we do insteadStage-gated tranches, each funded only when the last has earned it.

What answers them

Four problems. One governed data foundation.

Fragmented and expensive estates are answered by Data Modernization; untrusted data by AI Readiness; underused data by AI Enablement. The foundation is built once, and every new use case reuses it.

See the three services

Business outcomes

What changes when the foundation works.

  • Faster decisions

    Trusted information at the moment of decision.

  • Lower data friction

    Less duplication and manual reconciliation.

  • AI-enabled analytics

    Trusted AI answers on governed data, not an analytics queue.

  • Modern operations

    Platforms built for how the organization runs.

  • AI-ready data

    A foundation AI can use in production, not only in pilots.

  • Measurable value

    Every investment tied to revenue, cost, risk or speed.

Outcomes, measured

Measure the value, not the activity.

Activity is easy to count and proves little. Every outcome has a KPI, a baseline taken in Diagnose, and a result in the same unit. Shown for a hospital system.

OutcomeWhat programs usually countWhat we measure instead
Faster decisionsReports and dashboards deliveredDays from month-end close to the executive quality and finance pack
Lower data frictionData sources onboardedAnalyst hours a month spent reconciling clinical and financial numbers
AI-ready dataA data quality scoreShare of priority datasets that pass the ten AI-ready properties
AI in productionPilots launched and models deployedTime from an approved use case to a first working version (10–16 weeks on the foundation, against 6–12 months on earlier projects)
Modern operationsTables and applications migratedAnnual run cost of legacy platforms retired (licenses, infrastructure, support)
Clinical value, e.g. sepsisAlerts firedTime to antibiotics; SEP-1 bundle compliance

How the numbers are kept honest

  • Baseline first: measured in Diagnose, over a baseline period agreed with the metric owner.
  • Basis marked: measured, reported or observed.
  • Reported at every stage gate, so each tranche earns the next.

Executive decisionsFrom architecture decisions to executive ones

The decisions our work is designed to support.

  • What should we invest in?
  • What should we stop?
  • What do we modernize first?
  • Who owns the data?
  • Which AI use cases deserve funding?
  • What must we build internally?
  • Build or buy?
  • How will we measure value?

Healthcare & life sciences

Start with the business question.

Healthcare is where our record runs deepest; life sciences builds on the same foundation. The questions we hear most:

Healthcare

  • Which patient is deteriorating toward sepsis, hours before it is obvious?
  • Is this a large-vessel occlusion, and how did patients like this one recover?
  • Who is this patient across every encounter, payer and setting?
  • Why are claims denied, and which denials could we have prevented?

Healthcare in depth

Life sciences & pharma

  • Can our real-world data stand up to regulators and payers?
  • Which sites will actually recruit this patient population, and when?
  • Which physicians should we reach, through which channel, with what message?
  • Are we seeing every safety signal, as early as we could?

Life sciences in depth

Sepsis, stroke and drug-safety solutions are built on the foundation. See what we have built →

See it applied to your estate

Have a data or AI challenge you're trying to solve?

We'll help you find where to start, and what matters most.

What happens next

  • A 30-minute conversation with a principal.
  • No pitch deck. No generic capability presentation.
  • A focused discussion about the problem you're trying to solve.
  • A written view of where to start.